{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-122296","form_type":"8-K","ticker":"ALEC","cik":"0001653087","company_name":"Alector, Inc.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.116704+00:00","generated_at":"2026-05-30T04:36:57.211969+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Alector reports Q3 net loss $42.2M ($0.43/share); cash $457.2M funds through 2026","bullets":["Cash, cash equivalents, investments $457.2M as of Sep 30, 2024, sufficient to fund operations through 2026.","Q3 2024 net loss $42.2M ($0.43 per share) vs $44.5M ($0.53) in Q3 2023; collaboration revenue $15.3M, up from $9.1M.","R&D expenses $48.0M driven by AL101 Phase 2 start; G&A $15.8M includes impairment from lab transition.","FY 2024 guidance: collaboration rev $60-70M, R&D $210-220M, G&A $60-70M.","INVOKE-2 (AL002) Phase 2 data due in 2024; INFRONT-3 (latozinemab) top-line late 2025/early 2026; PROGRESS-AD >1/3 enrolled."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-122296","json":"https://secwatch.observer/filing/0000950170-24-122296.json","markdown":"https://secwatch.observer/filing/0000950170-24-122296.md","text":"https://secwatch.observer/filing/0000950170-24-122296.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653087/000095017024122296/0000950170-24-122296-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653087/000095017024122296/alec-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:36:57.211969+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}